Minerva Neurosciences Inc (NASDAQ:NERV)

8.85
Delayed Data
As of 3:59pm ET
 +0.15 / +1.72%
Today’s Change
4.80
Today|||52-Week Range
10.15
+46.28%
Year-to-Date
No recent news for Minerva Neurosciences Inc.

Today’s Trading

Previous close8.70
Today’s open8.70
Day’s range8.60 - 8.88
Volume10,808
Average volume (3 months)153,789
Market cap$251.9M
Data as of 3:59pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+16.16%
Earnings growth (this year)-89.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.10-1.29%
ADXSAdvaxis Inc-0.07-4.12%
IMDZImmune Design Corp-0.10-2.25%
URGNUrogen Pharma Ltd-2.58-4.71%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 3, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$31.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Rémy Luthringer
President
Richard Russell
Corporate headquarters
Waltham, Massachusetts

Forecasts